中文版 | English

在结果中检索

CCPortal

浏览/检索结果: 共2条，第1-2条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Efficacy and safety of chiglitazar, a novel peroxisome proliferator-activated receptor pan-agonist, in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, phase 3 trial (CMAP) 期刊论文
Science Bulletin, 2021, 卷号: 66, 期号: 15
作者:  Ji L.;  Song W.;  Fang H.;  Li W.;  Geng J.;  Wang Y.;  Guo L.;  Cai H.;  Yang T.;  Li H.;  Yang G.;  Li Q.;  Liu K.;  Li S.;  Liu Y.;  Shi F.;  Li X.;  Gao X.;  Tian H.;  Ji Q.;  Su Q.;  Zhou Z.;  Wang W.;  Zhou Z.;  Li X.;  Xu Y.;  Ning Z.;  Cao H.;  Pan D.;  Yao H.;  Lu X.;  Jia W.
收藏  |  浏览/下载：37/0  |  提交时间：2021/09/01
Carfloglitazar  Chiglitazar  Glycemic control  Insulin resistance  PPAR pan-agonist  Type 2 diabetes  
Clinical presentations and outcomes of SARS-CoV-2 infected pneumonia in pregnant women and health status of their neonates 期刊论文
Science Bulletin, 2020, 卷号: 65, 期号: 18
作者:  Xu L.;  Yang Q.;  Shi H.;  Lei S.;  Liu X.;  Zhu Y.;  Wu Q.;  Ding X.;  Tian Y.;  Hu Q.;  Chen F.;  Geng Z.;  Zeng X.;  Lin L.;  Cai X.;  Wu M.;  Wang Z.;  Wang Z.;  Xia G.;  Wang L.
收藏  |  浏览/下载：28/0  |  提交时间：2021/09/01